Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 159–159 | Cite as

Ipilimumab/nivolumab

Hypophysitis: case report
Case report
  • 22 Downloads

Reference

  1. Oh MS, et al. Deep and Durable Response with Combination CTLA-4 and PD-1 Blockade in Mismatch Repair (MMR)-proficient Endometrial Cancer. Journal of Immunotherapy 42: 51-54, No. 2, Feb 2019. Available from: URL: http://doi.org/10.1097/CJI.0000000000000244 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations